OR4F1P

Q-omics provides the consensus-scored OR4F1P profile across patient tissues and cancer cell-line models. OR4F1P expression is associated with patient survival in 2 of 34 cancer types, with the highest sampling consensus in KIRC. Additionally, OR4F1P RNA expression shows 513 significant gene co-expression associations, with the highest sampling consensus in STAD. Together, these results highlight KIRC, and STAD as cancer lineages where OR4F1P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes OR4F1P survival associations across molecular data types. OR4F1P RNA expression shows survival associations in the most cancer types (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

OR4F1P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	2	KIRC (36)	view →

This table ranks reproducible OR4F1P RNA expression–survival associations across cancer types. High OR4F1P expression shows unfavorable associations in KIRC and LIHC. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .008). Together, the overview and detailed table identify KIRC as the clearest survival context for OR4F1P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
LIHC	DFS	Tertile	All	0.163	0.556	.012	18	view →

Pink = unfavorable, green = favorable. all 2 lineages →

OR4F1P-KIRC (DFS)

Explore this curve interactively →